share_log

Pure Extracts Exports First Shipment Of Cannabis Oil Extracts To German Pharma

Pure Extracts Exports First Shipment Of Cannabis Oil Extracts To German Pharma

純提取物向德國製藥出口第一批大麻油提取物
Benzinga Real-time News ·  2022/03/16 11:55

Pure Extracts Technologies Corp. (CSE:PULL) (OTC:PRXTF) (XFRA: A2QJAJ) has successfully exported its first batch of cannabis oil extracts to a German pharmaceutical company under a Health Canada export permit.

純萃取技術公司(CSE：Pull)(OTC：PRXTF)(XFRA：A2QJAJ)成功根據加拿大衞生部的出口許可證，該公司向一家德國製藥公司出口了第一批大麻油提取物。

Pure Extracts purchased Canadian grown, EU-GMP certified, dry cannabis flower and extracted it into 65% pure THC full spectrum oil (FSO) and into 85% pure THC distillate.

純提取物購買加拿大種植，歐盟-GMP認證，幹大麻花和將其提取到65%純THC全光譜油(FSO)和85%純THC餾分中。

These extracts will be furthered processed in Germany into an ultra-pure form of THC for medicinal purposes.

這些提取物將在德國進一步加工成用於醫療目的的超純形式的THC。

This initial sale will pave the way for longer term supply agreements into Germany, Europe's most important market and the company plans to continue seeking export opportunities for its products in other European countries wherever they can be legally sold.

這筆初步銷售將為進入德國的長期供應協議鋪平道路，德國是歐洲最重要的市場，該公司計劃繼續為其產品在其他歐洲國家尋找出口機會，無論這些產品在哪裏可以合法銷售。

Pure Extracts CEO, Ben Nikolaevsky, remarked, "It is gratifying to have had our concentrates selected by a German pharmaceutical company for use in their medical products. We are excited about the entire European market opportunity for our extracts."

Pure Extracts首席執行官本·尼古拉夫斯基，他説：“我們很高興我們的濃縮物被一家德國製藥公司選中，用於他們的醫療產品。我們對我們的提取物在整個歐洲市場的機會感到興奮。”

Photo: Courtesy of Tom Fisk from Pexels

圖片：由Pexels的Tom Fisk提供

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論